Skip to menu Skip to content Skip to footer

2025

Journal Article

A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus

Young, Andrew, Kolekar, Sharada, Alvarez Mendoza, Carlos, Jaberolansar, Noushin, Modhiran, Naphak, Webb, Tim, McCuaig, Robert, Kommajosyula, Varsha, Tardiota, Nicolas, Dy, Quimbe, Amarilla, Alberto A., Dalrymple, Rhiannon L., Gillard, Marianne, Dutton, Julie L., Magdalena, Juana, Vandendriessche, Frank, Smal, Jean, Young, Paul R., Watterson, Daniel, Hanon, Emmanuel J. and Chappell, Keith J. (2025). A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus. PLOS Pathogens, 21 (7) e1013312, e1013312-7. doi: 10.1371/journal.ppat.1013312

A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus

2024

Journal Article

HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors

Tardiota, Nicolas, Jaberolansar, Noushin, Lackenby, Julia A., Chappell, Keith J. and O’Donnell, Jake S. (2024). HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors. Virology Journal, 21 (1) 14, 14. doi: 10.1186/s12985-024-02288-z

HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors